The Zero100 Podcast

Zero100
  • 4,8 (13)
  • ТЕХНОЛОГИИ
  • ЕЖЕНЕДЕЛЬНО

Welcome to Zero100, the “unboring” supply chain podcast. Each week, Zero100's researchers, analysts, and data scientists deliver sharp takes on the news, delve into new research, and interview leaders at the forefront of supply chain’s digital revolution, giving you the insights you need to drive growth and resilience.

  1. -2 ДН.

    Risky Business: Cybersecurity, Sustainability, and Ethics in the Age of AI

    AI can accelerate a fully digital supply chain, but it can also bring cyberattacks, ethical dilemmas, and sustainability risks. Zero100 Principal Analyst Suzanne Lindsay and VPs, Research Geraint John and Kelly Coutinho explore the threats faced by leaders today and what they can do to protect their organizations. Why cybersecurity is the CSCO’s problem after all (02:47) Fighting AI threats with AI (06:29) A blueprint for cyber-resilient supply chains (09:10) Can AI power true sustainability? (12:01) Safeguarding the human workforce in the agentic AI era (18:01) The dark side vs the gains: Striking the AI balance (20:24)

    22 мин.

  2. 25 АВГ.

    Is Tim Cook Still the Leader Apple Needs?

    Tim Cook has generated more than $3 trillion in shareholder value as Apple’s CEO, yet tariff pressures and the AI arms race are putting his operational rigor to the test. On the Zero100 Podcast, Chief Research Officer Kevin O’Marah and VP, Research Geraint John dissect whether Cook’s “balanced excellence” can keep Apple relevant and resilient in a morphing trade landscape.  Tim Cook vs Steve Jobs: Who was the better CEO? (00:35) From leader to laggard: Apple's product innovation downturn (02:42)  Trade, tariffs, and Trump (06:42) The plausibility of a US-made iPhone (09:26) Reflections of Cook’s big bet on China (11:59) What aspiring COOs can learn from Cook’s legacy (14:09) Is it time for Cook to pass the baton? (19:18)

    22 мин.

  3. 18 АВГ.

    Inside Pfizer's Evolving Pharma Supply Chain

    The COVID pandemic was a stress test for Pfizer’s vaccine supply chain – and a powerful catalyst for change. This week, Barbara Garcia (VP, Americas Supply Chain) and Fiona Ardagh (VP, EMEA Supply Chain) tell Zero100 Principal Analyst Jenna Fink how they built a more agile, integrated, and resilient supply chain to meet surging demand and prepare for future challenges.   What it was like working at Pfizer during the pandemic (0:52)How the business adapted to meet new challenges (2:43)Addressing global supply chain weak spots (5:11)Powered by people: How talent kept Pfizer moving (7:17)Redefining customer experience and delivering breakthroughs (12:35)How AI and new tech are optimizing Pfizer's supply chain today (16:20)What’s next for Pfizer (19:40)

    22 мин.

  4. 11 АВГ.

    Unlocking the Hidden Cash in Your Supply Chain

    Caught between margin pressures and looming price hikes? The Zero100 team reveals how supply chain leaders can free up cash and boost profitability without sacrificing customer experience or revenue. Featuring: Research Analyst Jalen Thibou and Principal Analysts Jenna Fink and Suzanne Lindsay.  Why companies are struggling to hit cost and growth targets (1:54)Nailing the elusive balance between cost and growth (3:18)How Unilever and Gap model long-term cash flow leadership (4:32)Replicable cost optimization plays from Samsung and Lenovo (6:44)Your best reinvestment bets (8:41)Making the cost optimization mindset stick (12:46)

    15 мин.

  5. 4 АВГ.

    In the Age of Automation, How Do You Rightsize Your Workforce?

    Given the productivity wins AI and AI agents offer, cutting headcount might seem like an obvious strategic move. But real efficiency, org success, and long-term growth hinge on rightsizing, not downsizing. VP, Research Lauren Acoba and Principal Analysts Jenna Fink and Caroline Chumakov explore why end-to-end workflow reinvention, redefining roles, and reskilling talent are a necessity in the agentic age.  The critical difference between downsizing and rightsizing (00:40)Avoiding the trap of short-termism in workforce planning (2:50)Lessons in building human-agent workflows (6:41)How leadership paradigms shift in the agentic era (8:41)Shaping the supply chain worker of the future (12:30)Roles that are growing and declining in the face of AI (14:28)Strategies to cultivate more Translators in your supply chain (16:34)Balancing headcount reduction with mindful reinvestment (18:47)What comes next: culture keepers and skills-based orgs (22:21)

    25 мин.

  6. 28 ИЮЛ.

    Freedom to Spend Smartly: Unpacking Bayer's Procurement Power Play

    In procurement, tight control over external spend is a golden rule for cost savings. But what would happen if leaders loosened the reins? Malik Akhtar, Chief Procurement Officer at Bayer Consumer Health, tells Zero100 VP, Research Geraint John how the company’s "Freedom to Spend Smartly" strategy is putting buying power in the hands of non-procurement users while keeping spend and supplier numbers in check. The why and the how of Freedom to Spend Smartly (00:56)  Initial concerns and selling the policy to the CFO (3:20) Managing governance and non-compliance (4:24)  How AI is helping  procurement leaders and rookie requisitioners (5:22)  Decreasing costs, frictionless service, and other early benefits (7:09)  Rethinking procurement skills, responsibilities, and incentives (11:28) What’s next for Freedom to Spend Smartly (15:18)

    18 мин.

  7. 21 ИЮЛ.

    New Tariffs, New Tech, New Remit: Reflections from Off the Grid 2025

    What's keeping today’s top supply chain leaders up at night? And what opportunities are they most excited about? The Zero100 team shares their biggest takeaways from Off the Grid 2025, our recent gathering of 50+ CSCOs and COOs in Ireland, exploring everything from the future of tariffs and agentic AI to the power of fusion teams and the expanding COO remit. Featuring: Content Director Allyssia Alleyne and VPs, Research Kelly Coutinho and Geraint John. First things first: What is Off the Grid? (1:50) Key themes: New rules of global trade and the rise of agentic AI (02:48) How supply chain leaders are thinking about tariffs now (06:12)Evolving perspectives on the ROI of AI (10:20) China’s digital innovation advantage (11:28) Visibility, agility, and cross-functionality: CSCO and COO priorities for the rest of 2025 (13:53)

    20 мин.

  8. 14 ИЮЛ.

    Novo Nordisk & Eli Lilly: Manufacturing Lessons from the GLP-1 Giants

    As GLP-1 drugs like Ozempic and Zepbound took the world by storm, Novo Nordisk and Eli Lilly faced a massive question: how do you fill the need at maximum speed? This week, we pull back the curtain on the strategies that allowed both companies to scale their manufacturing and cement market dominance, offering takeaways for any leader navigating unprecedented demand. Featuring: Principal Analysts Caroline Chumakov and Jenna Fink. Contextualizing the appetite for GLP-1s (0:46)Build, buy, acquire: How Novo Nordisk and Eli Lilly are meeting demand (04:05)The implications of Novo Nordisk’s $16.5 billion Catalent acquisition (05:53)How to decide whether to acquire or outsource (07:23)Where in the world is GLP-1 manufacturing going next? (10:36)DTC, telehealth, and the future of GLP-1 channel strategy (13:16)How AI is driving pharma innovation at Novo Nordisk, Eli Lilly, Johnson & Johnson, and Merck (17:13)

    26 мин.
См. все (72)

Оценки и отзывы

4,8
из 5
Оценок: 13

Об этом подкасте

Welcome to Zero100, the “unboring” supply chain podcast. Each week, Zero100's researchers, analysts, and data scientists deliver sharp takes on the news, delve into new research, and interview leaders at the forefront of supply chain’s digital revolution, giving you the insights you need to drive growth and resilience.

Информация

  • Автор
    Zero100
  • Годы выхода
    2022 - 2025
  • Выпуски
    72
  • Ограничения
    Без ненормативной лексики
  • Авторские права
    © 355795
  • Сайт подкаста
    The Zero100 Podcast

Вам может также понравиться